THE CURE INDEX
Helio Cure's evidence score based on human clinical trials for red light therapy.
Scarring hair loss, also known as cicatricial alopecia, is a group of conditions in which hair follicles are destroyed and replaced with scar tissue, causing permanent hair loss.
In 4 human studies covering 44 participants, red light therapy was found effective for scarring hair loss. The CURE Index rated this condition 74 out of 100, indicating strong confidence.
The studies reported that red light therapy was associated with reduced inflammation and increased hair thickness in scarring hair loss.
All 4 studies were clinical trials, and each of the 4 reported effective outcomes.
Most protocols used red light near 630 nm, within a broader range of 625 to 970 nm, in sessions lasting 2.5 to 20 minutes, 2 to 10 times per week, over 10 to 180 days of therapy.
EVIDENCE AT A GLANCE
The numbers behind the verdict.
MOST CITED WAVELENGTH
The wavelength appearing most often in studies that showed benefit for scarring hair loss.
630 nmTREATMENT PROTOCOL RANGES
The lowest and highest values used across scarring hair loss studies.
| PARAMETER | RANGE |
|---|---|
| Wavelength | 625-970 nm |
| Session Duration | 2.5-20 minutes |
| Session Frequency | 2-10 per week |
| Therapy Duration | 10-180 days |
Note: We have excluded meta-analyses and reviews from scoring, but the list of human studies below contains them for your reference.
5 Human Studies on Red Light Therapy for Scarring Hair Loss
Eyebrows Regrew Hair After LED Therapy for Scarring Hair Loss
Among 16 women aged 60 to 74 with frontal fibrosing alopecia, a scarring hair loss that pushes the front hairline back, a 2021 clinical trial tested LED therapy for eyebrow loss. Red LED light at 625 to 635 nm was applied to both eyebrows and the front hairline from a distance of 5.91 inches, in 9.07-minute sessions given once a week for 10 weeks, at a fluence of 37 J/cm². The authors concluded that total eyebrow hair count, along with the number of thick and medium-thick hairs, increased significantly after 10 sessions, with the improvement described as cosmetically acceptable. The therapy was reported as well tolerated and safe.
- Study Type
- Clinical Trial
- Participants
- 16
- Treated Area
- Face
- Wavelength(s)
- 625-635 nm
- Distance
- 5.91 inches
- Session Duration
- 9.07 minutes
- Session Frequency
- 10 per week
- Therapy Duration
- 70 days
- Study Scope
- Frontal Fibrosing Alopecia (FFA)
Study Title: Novel Application of Light-Emitting Diode Therapy in the Treatment of Eyebrow Loss in Frontal Fibrosing Alopecia.
Scarring Hair Loss Patients Found Light Therapy Beneficial for Regrowth
A 2020 clinical trial examined low-level light therapy for scarring hair loss in 4 patients with lichen planopilaris, an inflammatory scalp disease that scars hair follicles. Red and near-infrared light, from about 625 to 970 nm, was applied to the scalp, and in some cases to the lining inside the mouth. Sessions ran roughly 2.5 to 20 minutes, 2 to 7 times per week. All 4 patients appeared to improve, with less inflammation, symptoms disappearing, and visible hair regrowth. No side effects were reported in these cases.
- Study Type
- Clinical Trial
- Participants
- 4
- Treated Area
- Head, Mouth
- Wavelength(s)
- 625-635, 630, 633, 650, 660, 808, 890, 970 nm
- Session Duration
- 2.5 minutes, 5 minutes, 7 minutes, 8 minutes, 13.78 minutes, 15 minutes, 20 minutes
- Session Frequency
- 2, 7 per week
- Study Scope
- Lichen Planopilaris
Study Title: Lichen Planopilaris and Low-Level Light Therapy: Four Case Reports and Review of the Literature About Low-Level Light Therapy and Lichenoid Dermatosis.
LED Therapy Eased Symptoms in Scarring Hair Loss Trial
Researchers in Poland tested a red LED device as an add-on therapy for 16 women aged 41 to 76, 8 with frontal fibrosing alopecia (FFA), a scarring hair loss that pushes the front hairline back, and 8 with lichen planopilaris (LPP), an inflammatory scalp disease that scars hair follicles, in a 2019 clinical trial. The superluminescent LED delivered 630 nm red light once a week for 10 weeks, at an irradiance of 70 mW/cm² and a total dose of 44.45 J/cm² to the scalp. The study found that scores for how active the scalp inflammation was and for how severe the frontal fibrosing alopecia was both dropped significantly after treatment, and the number of thick hairs in the treated area increased, though medium and thin hair counts did not change. The therapy was described as well tolerated.
- Study Type
- Clinical Trial
- Participants
- 16
- Treated Area
- Scalp
- Wavelength(s)
- 630 nm
- Therapy Duration
- 10 days
Study Title: Application of superluminescent diodes (sLED) in the treatment of scarring alopecia - A pilot study.
Review Reported Laser Treatment Reduced Scarring Hair Loss
In 2019, a review examined treatment options for scarring hair loss and other forms of hair loss in women of color. Among the interventions discussed, low-level laser treatment used red and near-infrared light, from 620 to 1400 nm, applied 3 times per week over about 182 days, in a combined 269 participants. According to the review, low-level laser treatment was associated with improved hair density and thickness on some measures, though it showed no improvement on assessors' or patients' overall ratings of change. Reported side effects included headache, pain, and itching.
- Study Type
- Review
- Participants
- 269
- Treated Area
- Head
- Wavelength(s)
- 620-780, 780-1400 nm
- Session Frequency
- 3 per week
- Therapy Duration
- 182 days
Study Title: Current and emerging treatment strategies for hair loss in women of color.
Low-Level Laser Reduced Inflammation in Scarring Hair Loss Patients
8 adults (5 women and 3 men, median age 65) with lichen planopilaris (LPP), an inflammatory scalp disease that scars hair follicles, took part in a 2018 clinical trial of low-level laser therapy (LLLT) for scarring hair loss. A red LED device delivered 630 nm light at a dose of 4 J/cm² for 15 minutes daily over 6 months, targeting 3 areas at the front of the scalp and 2 areas on existing scarring patches. Scores for how active the scalp inflammation was dropped on average after 6 months of treatment. Hair thickness appeared to increase at both the 3 and 6 month marks compared with baseline, though the gain was smaller by 6 months than at 3.
- Study Type
- Clinical Trial
- Participants
- 8
- Treated Area
- Scalp
- Wavelength(s)
- 630 nm
- Session Duration
- 15 minutes
- Session Frequency
- 7 per week
- Therapy Duration
- 180 days
Study Title: Effectiveness of low-level laser therapy in lichen planopilaris.
The CURE Index (Clinical Understanding of Red-light Evidence) by Helio Cure is a 0-100 evidence score based on published human clinical trials. Higher scores mean stronger evidence. Read full methodology →
Data is powered by AI and reviewed by the Helio Cure team.
This page is for educational purposes only. Not medical advice. Consult a healthcare provider before starting red light therapy. Helio Cure does not diagnose, treat, or cure any medical condition.
Last updated: Aug 10, 2026